We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$8.23B
1-Year Est. Return
17.62%
This Fund
S&P 500
This Quarter
Est. Return
+3.82%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.87B
AUM Growth
-$13.1M
(-0.34%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-3.37%
Top 10 Holdings %
Top 10 Hldgs %
23.72%
Holding
372
New
16
Increased
96
Reduced
171
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$7.62M |
| 2 |
Constellation Brands
STZ
|
+$4.4M |
| 3 |
CHX
ChampionX
CHX
|
+$3.45M |
| 4 |
Stanley Black & Decker
SWK
|
+$3.4M |
| 5 |
Valero Energy
VLO
|
+$2.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$41.6M |
| 2 |
Check Point Software Technologies
CHKP
|
+$11.3M |
| 3 |
Medtronic
MDT
|
+$9.78M |
| 4 |
Franklin Resources
BEN
|
+$8.22M |
| 5 |
CELG
Celgene Corp
CELG
|
+$7.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 17.92% |
| 3 | Financials | 11.59% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Novartis
NVS
$301B
| $8.32M | 0.22% |
122,906
-1,574
| -1% | -$109K |
|
102
ConocoPhillips
COP
$145B
| $8.27M | 0.21% |
118,735
+5,369
| +5% | +$358K |
|
103
EOG Resources
EOG
$77.5B
| $8.25M | 0.21% |
66,293
+263
| +0.4% | +$30.6K |
|
104
Duke Energy
DUK
$98.4B
| $8.22M | 0.21% |
103,966
-1,632
| -2% | -$126K |
|
105
Air Products & Chemicals
APD
$66.8B
| $8.2M | 0.21% |
52,683
-490
| -0.9% | -$80.1K |
|
106
United Parcel Service
UPS
$89.5B
| $8.06M | 0.21% |
75,874
-2,526
| -3% | -$284K |
|
107
Walt Disney
DIS
$167B
| $7.89M | 0.2% |
75,323
+165
| +0.2% | +$16.9K |
|
108
Cintas
CTAS
$82.7B
| $7.71M | 0.2% |
166,588
-3,892
| -2% | -$175K |
|
109
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $7.56M | 0.2% |
93,384
-5,000
| -5% | -$404K |
|
110
Amgen
AMGN
$209B
| $7.38M | 0.19% |
39,999
-29
| -0.1% | -$5.13K |
|
111
Hain Celestial
HAIN
$44.4M
| $7.32M | 0.19% |
245,643
-34,005
| -12% | -$975K |
|
112
American Express
AXP
$228B
| $7.3M | 0.19% |
74,521
+5,242
| +8% | +$515K |
|
113
Starbucks
SBUX
$121B
| $6.54M | 0.17% |
133,942
-26,735
| -17% | -$1.52M |
|
114
DuPont de Nemours
DD
$18.7B
| $6.54M | 0.17% |
39,181
+868
| +2% | +$145K |
|
115
Colgate-Palmolive
CL
$73.3B
| $6.51M | 0.17% |
100,451
-5,313
| -5% | -$348K |
|
116
Middleby
MIDD
$6.03B
| $6.43M | 0.17% |
61,586
-48,973
| -44% | -$5.54M |
|
117
Vanguard FTSE Europe ETF
VGK
$30.8B
| $6.34M | 0.16% |
112,944
-2,564
| -2% | -$151K |
|
118
BP
BP
$114B
| $6.26M | 0.16% |
145,753
-1,714
| -1% | -$72K |
|
119
Oracle
ORCL
$367B
| $5.95M | 0.15% |
135,100
-23,624
| -15% | -$1.09M |
|
120
iShares Russell 2000 ETF
IWM
$80.2B
| $5.86M | 0.15% |
35,774
-800
| -2% | -$128K |
|
121
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
| $5.71M | 0.15% |
110,180
+1,639
| +2% | +$88.8K |
|
122
Sherwin-Williams
SHW
$83.7B
| $5.63M | 0.15% |
41,442
-3,237
| -7% | -$419K |
|
123
Caterpillar
CAT
$373B
| $5.57M | 0.14% |
41,076
-993
| -2% | -$148K |
|
|
APC
124
DELISTED
Anadarko Petroleum
APC
| $5.43M | 0.14% |
74,154
-55
| -0.1% | -$3.73K |
|
125
CF Industries
CF
$19.3B
| $5.12M | 0.13% |
115,242
-14,288
| -11% | -$583K |
|
Similar funds
OC
LGF
CCM
CL
WJWM
WA
GGHC
CCM
Welch & Forbes's Q2 2018 Portfolio in Review
As of Q2 2018, Welch & Forbes held 372 positions worth $3.87B, down 0.34% from $3.88B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Welch & Forbes withdrew a net $131M in Q2 2018, closing 13 positions and reducing 171 holdings. Its most notable exit was Chubb, an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.
Against the trend, Welch & Forbes opened a new position in ChampionX worth $3.52M.
- Welch & Forbes's largest Q2 2018 buy was ChampionX: 84,371 shares worth $3.52M.
- Welch & Forbes added most to Thermo Fisher Scientific in Q2 2018, an estimated $7.62M increase.
- Welch & Forbes's biggest Q2 2018 reduction was Franklin Resources, cutting an estimated $8.22M.
- Welch & Forbes fully exited Chubb in Q2 2018, selling an estimated $41.6M.
- Welch & Forbes's ten largest holdings make up 24% of its $3.87B portfolio in Q2 2018.
- Welch & Forbes opened 16 new positions and closed 13 in Q2 2018.
- Welch & Forbes's portfolio value fell 0.34% quarter-over-quarter to $3.87B.
Based on Welch & Forbes's 13F filing for Q2 2018, filed 16 Jul 2018.